Fasturtec 1.5 mg / ml powder and solvent for concentrate for solution for infusion

Shortage
Licence status
Authorised: 23/02/2001
Active substances
Rasburicase
Dosage Form
Powder and solvent for concentrate for solution for infusion
Licence number
EU/1/00/170/001-002
Licence holder
Sanofi Winthrop Industrie

Product documents

Licence information

ATC code
V03AF Detoxifying agents for antineoplastic treatment, V03AF07 rasburicase
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
23/02/2001